NCT03484975

Brief Summary

Collection of coronary images with a hybrid IVUS OCT system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2018

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 2, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2019

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 18, 2021

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

1 year

First QC Date

March 12, 2018

Last Update Submit

August 28, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Collection of the first human coronary images with the hybrid IVUS OCT technology

    The hybrid IVUS OCT system permits simultaneous and co-registered acquisition of IVUS and OCT coronary images. IVUS and/or OCT series can be recorded up to 10 cm of the vessel length or up to 20 s of imaging. The physician will review 10 frames and evaluate independently IVUS images, OCT images and the combined IVUS-OCT images for the ability to identify and characterize coronary lesion categories: lipid plaque, calcified plaque, fibrous plaque, thin fibrous cap, positive remodelling and plaque burden. Results, for each frame and imaging modality, of lesion assessment will be tabulated as: a) non-assessable, b) assessable and present, c) assessable and absent. The Clinical Report Form captures tabulated sections for each imaging modality and specific frame selected for lesion evaluation. Results will be presented qualitatively and quantitative as categorical calculations. Image interpretation will be performed independently and blinded to clinical and angiographic information.

    Clinical Report Forms (capturing image analysis) will be completed for each case no later then 72 hours after the procedure.

Study Arms (1)

Observation group

OTHER

Patients undergoing coronary angiography and intravascular imaging for either diagnostic purposes or for PCI following a presentation with either stable angina or an acute coronary syndrome.

Device: Observation group

Interventions

Collect coronary images with a hybrid IVUS OCT system.

Observation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient is at least 18 years old.
  • Patients arriving for coronary angiography or possible PCI with stable angina or acute coronary syndrome (including unstable angina, NSTEMI or STEMI).
  • Patients with STEMI may be undergoing subsequent staged PCI to additional coronary stenoses after the index STEMI event has been successful treated with primary PCI.
  • Vascular access of at least 6F.
  • Patient provides informed, written consent for participation in the study.
  • A target lesion is present in a suitable artery for intravascular imaging.

You may not qualify if:

  • Angiographic evidence of severe calcification
  • Marked tortuosity that precludes imaging of a target coronary artery.
  • GFR (Glomerular filtration rate) \<35 mL/min.
  • Patients in cardiogenic shock.
  • Women of child bearing potential, in whom pregnancy cannot be excluded.
  • Patients of age \< 18 years old.
  • Patients with an allergy to contrast.
  • Patients unable to grant informed, written consent for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hamilton General Hospital

Hamilton, Ontario, L8L 2X2, Canada

Location

MeSH Terms

Conditions

Angina, StableAcute Coronary Syndrome

Condition Hierarchy (Ancestors)

Angina PectorisMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tej Sheth, MD

    Hamilton General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2018

First Posted

April 2, 2018

Study Start

August 1, 2018

Primary Completion

August 6, 2019

Study Completion

August 18, 2021

Last Updated

August 31, 2021

Record last verified: 2021-08

Locations